Cardiff Oncology Inc (CRDF)
2.98
+0.05
(+1.71%)
USD |
NASDAQ |
Jun 10, 16:00
2.97
-0.01
(-0.34%)
After-Hours: 20:00
Cardiff Oncology Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2018 | 69.81% |
June 30, 2018 | -82.84% |
March 31, 2018 | -265.8% |
December 31, 2017 | -107.3% |
September 30, 2017 | -283.7% |
June 30, 2017 | -231.5% |
March 31, 2017 | -548.6% |
December 31, 2016 | -762.6% |
Date | Value |
---|---|
September 30, 2016 | -376.4% |
June 30, 2016 | -296.0% |
March 31, 2016 | -156.7% |
December 31, 2015 | -151.6% |
September 30, 2015 | -202.7% |
June 30, 2015 | -36.74% |
March 31, 2015 | -38.95% |
December 31, 2014 | 72.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Biolase Inc | 32.93% |
Tenon Medical Inc | 65.37% |
AIM ImmunoTech Inc | 80.00% |
Protalix BioTherapeutics Inc | 30.58% |
Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -51.37% |
Return on Assets | -44.89% |
Return on Invested Capital | -51.37% |
Profit Margin (Quarterly) | -4.88K% |
Operating Margin (Quarterly) | -5.33K% |
Return on Net Operating Assets | -1.16K% |